Medicare Enrolled

Dr. Matt Khoshnevis, M.D.

Pulmonary Disease · Houston, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
6565 FANNIN, Houston, TX 77030
7134413020
In practice since 2006 (19 years)
NPI: 1215032305 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khoshnevis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khoshnevis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Khoshnevis

Dr. Matt Khoshnevis is a pulmonary disease in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Khoshnevis performed 643 Medicare services across 308 unique beneficiaries.

Between the years covered by Open Payments, Dr. Khoshnevis received a total of $555 from 9 pharmaceutical and/or device companies across 11 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Khoshnevis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 643 Medicare services$ $555 industry payments

Medicare Practice Summary

Medicare Utilization ↗
643
Medicare services
Bottom 36% in TX for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
308
Unique beneficiaries
$131
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~34 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Critical care, first 30-74 min390$172$672
Hospital follow-up visit, moderate complexity156$63$211
Hospital follow-up visit, high complexity34$93$302
Insertion of non-tunneled central venous tube for infusion (5 years or older)23$68$436
Insertion of artery tube for blood sampling or infusion through skin21$35$228
Critical care, each additional 30 minutes19$87$328
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.8% high complexity
0.0% medium
93.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$555
Total received (2018-2024)
Avg $111/year across 5 years
Bottom 34% in TX for pulmonary disease
9
Companies
11
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$555 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$37
2023
$19
2022
$196
2019
$167
2018
$137

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$196
GENZYME CORPORATION
$87
Boehringer Ingelheim Pharmaceuticals, Inc.
$79
CARDIVA MEDICAL, INC.
$77
Abbott Laboratories
$37
Maquet Cardiovascular U.S. Sales, L.L.C.
$33
ABBVIE INC.
$19
Medtronic Vascular, Inc.
$15
Sunovion Pharmaceuticals Inc.
$12
Top 3 companies account for 65.3% of total payments
Associated products mentioned in payments ›
AVEIR · AVVIGO Guidance System · AVYCAZ · DUPIXENT · General - Therapies · Heartstring · Reveal LINQ · Utibron · VASOVIEW · Vascular Closure Device
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $86 per 100 Medicare services performed
Looking for a pulmonary disease in Houston?
Compare pulmonary diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
136
Per 100K population
2.9
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data✓ Medicare Util.Annual (CY lag)
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Khoshnevis is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Khoshnevis experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Khoshnevis performed 390 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khoshnevis receive payments from pharmaceutical companies?
Yes. Dr. Khoshnevis received a total of $555 from 9 companies across 11 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khoshnevis's costs compare to other pulmonary diseases in Houston?
Dr. Khoshnevis's average Medicare payment per service is $131. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khoshnevis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Houston
Browse pulmonary diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc..
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →